METTL7B-stabilized lncRNA-MIR22HG to drive p53-mediated neuronal apoptosis via the ubiquitinating JARID2 in cerebral ischemia/reperfusion injury
Cell Biology and Toxicology · 2026
DOI: 10.1007/s10565-026-10157-4 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cell Biology and Toxicology, 2026. Verfasst von Hao Zhang und 3 weiteren Autor:innen. Beteiligte Einrichtung: Guangdong University of Technology, Guangzhou, China. boyi890608@gdut.edu.cn. Hauptthemen laut MEDLINE: Apoptosis, RNA, Long Noncoding, Reperfusion Injury, Tumor Suppressor Protein p53. Die Arbeit nennt 58 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Guangdong Province.
Abstract (Originalsprache)
Ischemic stroke (IS) constitutes a leading driver of mortality and morbidity worldwide, with neuronal apoptosis representing a key pathological process. Accordingly, our objective was to delve into the implications of a novel signaling axis of the m6A methyltransferase METTL7B, lncRNA-MIR22HG, and JARID2 in driving neuronal apoptosis throughout cerebral ischemia/reperfusion (I/R) injury (CIRI). Mice subjected to middle cerebral artery occlusion/reperfusion (MCAO/R) and N2a cells exposed to oxygen-glucose deprivation/reoxygenation (OGD/R) were, respectively, established as in vivo and in vitro I/R models. METTL7B was markedly up-regulated after I/R and enhanced the m6A methylation and stability of lncRNA-MIR22HG, significantly prolonging its transcript half-life and amplifying its biological effects on neuronal fate. Stabilized lncRNA-MIR22HG suppressed the ubiquitin-mediated degradation of JARID2, thereby increasing JARID2 abundance and activity. Elevated JARID2 promoted the assembly of the p53/p300/MDM2 transcriptional complex, which in turn up-regulated the levels of pro-apoptotic genes, ultimately exacerbating neuronal apoptosis alongside ischemic brain injury. Functionally, METTL7B overexpression aggravated neurological deficits, infarct volume, and neuronal apoptosis in vivo, whereas METTL7B knockdown alleviated ischemic damage and conferred robust neuroprotection. Collectively, these findings define a novel METTL7B/lncRNA-MIR22HG/JARID2 signaling axis that integrates RNA methylation, lncRNA stabilization, proteostasis, and transcriptional activation of apoptosis, and highlight METTL7B as a potential novel target for therapeutic strategies aimed at preventing and treating ischemic stroke.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Guangdong University of Technology, Guangzhou, China. boyi890608@gdut.edu.cn.
- Guangdong University of Technology, Guangzhou, China.
- Department of Cardiology, Guangdong Second Provincial General Hospital, Guangzhou, Guangdong, China.
- Guangdong University of Technology, Guangzhou, China. xiaoousun@gdut.edu.cn.
Förderung
- National Natural Science Foundation of China
- Natural Science Foundation of Guangdong Province
Zitieren
APA
Zhang, H., Li, M., Wu, Y., & Sun, X. (2026). METTL7B-stabilized lncRNA-MIR22HG to drive p53-mediated neuronal apoptosis via the ubiquitinating JARID2 in cerebral ischemia/reperfusion injury. Cell Biology and Toxicology. https://doi.org/10.1007/s10565-026-10157-4
Vancouver
Zhang H, Li M, Wu Y, Sun X. METTL7B-stabilized lncRNA-MIR22HG to drive p53-mediated neuronal apoptosis via the ubiquitinating JARID2 in cerebral ischemia/reperfusion injury. Cell Biology and Toxicology. 2026. doi:10.1007/s10565-026-10157-4
BibTeX
@article{Zhang2026,
author = {Zhang, Hao and Li, Meng and Wu, Yilin and Sun, Xiaoou},
title = {METTL7B-stabilized lncRNA-MIR22HG to drive p53-mediated neuronal apoptosis via the ubiquitinating JARID2 in cerebral ischemia/reperfusion injury},
journal = {Cell Biology and Toxicology},
year = {2026},
doi = {10.1007/s10565-026-10157-4}
}
EUVIMED